They’ll cost no more than $30 a vial and $55 for a box of pre-filled pens, which often retail for over $500. The Petersburg plant will be capable of producing up to 90 million vials and 50 ...

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first ...

The cost of a prescription for generic Humalog ranges between $44 and close to $100 on the website GoodRx. Lilly also is launching in April a biosimilar insulin to compete with Sanofi's Lantus.

Indian drugmakers Biocon, Eris Lifesciences, and Wockhardt are ramping up insulin production to capture a growing global opportunity, as market leader Novo Nordisk scales back its presence in ...

Patient satisfaction. More patients in the insulin pen group (77.1%) dialed at least one dose of insulin using the pen device, compared with 5% of patients who drew at least one dose using the ...

Studies in ambulatory care patients have also found that insulin pens have similar effects or improve glycemic control compared with insulin administered using vials and syringes. In a multicenter ...

NovoLog (insulin aspart) is a fast-acting insulin used for diabetes treatment. It’s injected 5 to 10 minutes before meals. It may be prescribed with other insulins or oral diabetes drugs.

Humulin N isn’t a type of regular insulin. Regular insulins are typically short-acting insulins, which take about 30 minutes to start working after they’re injected.